BALTIMORE, June 16,
2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the
global company behind one of the fastest-growing health and
wellness communities, OPTAVIA®, announced today that
its Board of Directors has declared a $1.64 quarterly cash dividend to its
stockholders. The quarterly cash dividend of $1.64 per share is payable on August 8, 2022 to stockholders of record as of
the close of business on June 28,
2022.
Medifast expects to maintain a program of paying dividends on a
quarterly basis. However, the declaration of dividends in the
future is subject to the discretion of the company's Board of
Directors, who will evaluate the company's dividend program from
time to time based on factors that it deems relevant.
About Medifast:
Medifast (NYSE: MED) is the global company behind one of the
fastest-growing health and wellness communities, OPTAVIA®,
which offers scientifically developed products, clinically proven
plans and the support of independent OPTAVIA Coaches and a
Community to help Customers achieve Lifelong Transformation, One
Healthy Habit at a Time®. As the publicly traded market leader by
revenue in the U.S. $7 billion weight
management industry, the company has impacted more than 2 million
lives through its Community of OPTAVIA Coaches, who teach
Customers how to develop holistic healthy habits through the
proprietary Habits of Health® Transformational System. Medifast was
recognized in 2022 as one of America's Best Mid-Sized Companies by
Forbes, in 2020 and 2021 as one of FORTUNE's 100 Fastest-Growing
Companies and was named to Forbes' 100 Most Trustworthy
Companies in America list in 2017. For more information,
visit MedifastInc.com or OPTAVIA.com and follow @Medifast on
Twitter.
Forward Looking
Statements
Please Note: This release contains "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995, Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended.
These forward-looking statements generally can be identified by use
of phrases or terminology such as "intend," "anticipate," "expect"
or other similar words or the negative of such terminology.
Similarly, descriptions of Medifast's objectives, strategies,
plans, goals or targets contained herein are also considered
forward-looking statements. These statements are based on the
current expectations of the management of Medifast and are subject
to certain events, risks, uncertainties and other factors. Some of
these factors include, among others: constraints, volatility or
disruptions in the capital markets or other factors affecting the
amount and timing of share repurchases under Medifast's accelerated
share repurchase program; risks associated with Medifast's
direct-to-consumer business model; the impact of rapid growth on
Medifast's systems; disruptions in Medifast's supply chain;
Medifast's inability to continue to develop new products;
effectiveness of Medifast's advertising and marketing programs,
including use of social media by independent OPTAVIA
Coaches; Medifast's inability to maintain and grow the network of
independent OPTAVIA Coaches; the departure of one or more
key personnel; Medifast's inability to protect against online
security risks, to protect its brand, or to protect against product
liability claims; Medifast's planned growth into domestic and
international markets; adverse publicity associated with Medifast's
products; Medifast's inability to continue declaring dividends;
fluctuations of Medifast's common stock market price; the impact of
the COVID-19 pandemic on Medifast's results and the severity,
length and ultimate impact of the COVID-19 pandemic on people and
economies; increases in competition, litigation, natural disasters,
acts of war, other geopolitical events, climate change, shareholder
activism, regulatory changes, inflation, labor shortages, supply
chain issues and the resulting impact on market conditions and
consumer spending; and the impact of changes in internal control
over financial reporting. Although Medifast believes that the
expectations, statements and assumptions reflected in these
forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement
in this release, as well as those set forth in its Annual Report on
Form 10-K for the fiscal year ended December
31, 2021, its Quarterly Report on Form 10-Q for the quarter
ended March 31, 2022, and other
filings filed with the United States Securities and Exchange
Commission, including its current reports on Form 8-K. All of the
forward-looking statements contained herein speak only as of the
date of this release.
MED-F
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medifast-inc-announces-quarterly-dividend-301569942.html
SOURCE Medifast, Inc.